Research Study List

Research Staff Directory:  Our team is available to answer your questions about our services and next steps.

Open Recruiting Trials

Closed Active Trials

  • Title: Analysis of Both Sex and Device Specific FactorRs on Outcomes in PAtients with Non-Ischemic Cardiomyopathy
    Trial ID: Bio Libra
  • Title: A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chest Wall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
    Trial ID:
    Trial ID: NRG-GY018
  • Title: A Phase III Trial of 6 Versus 12 Treatments of Adjuvant Folfox Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer
    Trial ID: C 80702
  • Title: A Phase III, Ranodmized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER-2 Negative Breast Cancer with Recurrence Score (RS) of (RS) of 25 or Less
    Trial ID: S 1007
  • Title: A Cohort Study to Evaluate Genetic Predictors for Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)
    Trial ID: E1Z11 (AIMSS Study)
  • Title: Program for the Assemnet of Clinical Cancer Tests (PACCT-1): Trial Assigning Individualized Options for Treatment (The TAILORx Trial)
    Trial ID: PACT-1/EL112
  • Title: A Randomized Phase II/III Study of Paciltaxel/Carboplatin/Metformin (NSC#91485) Versus Paciltaxel/Carboplatin/Placebo as Initital Therapy fro Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer
    Trial ID: G 0286B
  • Title: Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women with Breast Cancer
    Trial ID: A011104
  • Title: A Randomized Plase II Study of Perioperative mFOLFIRINOX versus Gemcitabine/nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma
    Trial ID: S 1505
  • Title: Phase III Study Comparing Single-Agent Olaparib or the Combination of Cediranib an Olaparib to Standard Platinum-Based Chemotherapy in Women with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    Trial ID: NRG-GY004
  • Title: A Phase 3, Randomized, Double--Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients with HRD- Positive Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
    Trial ID: Tesaro-PR-30-5017-C
  • Title: Androgen deprivation therapy and high dose radiotherapy with or without whole pelvic radiotherapy in unfavorable intermediate or favorable high risk prostate cancer: A phase III randomized trial
    Trial ID: R 0924
  • Title: A Randomized Phase II Trial for Patients with p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer
    Trial ID: NRG- HN002
  • Title: Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also receiving Cisplatin & Etoposide
    Trial ID: C 30610/ R 0538
  • Title: The Role of the Robotic Platform in Inguinal Hernia Surgery
    Trial ID: The Role of the Robotic Platform in Inguinal Hernia Surgery
  • Title: A blind prospective study of the performance of HE4 to predict recurrence in patients with advanced ovarian cancer, peritoneal carcinoma and tubal carcinoma
    Trial ID: FDI-78
  • Title: A Multicenter Prospective Study of CA 125 and HE4 Serum Biomarkers For Monitoring The Response To First-Line Therapy In Women With Primary Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancers Excluding Ovarian Tumors Of Low Malignant Potential
    Trial ID: FDI-79
  • Title: A Prospective, Multicenter Post Market Study to Evaluate and Compare the Clinical Outcomes, Pain and Patient Quality of Life after Open, Laparoscopic or Robotic Assisted Hernia (Incisional and Inguinal) Repair
    Trial ID: Intuitive Surgical
  • Title: A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)
    Trial ID: Testing reduced duration radiation therapy versus standard duration radiation therapy for prostate cancer
  • Title: A Randomized Phase II/III Study of Pegylated Liposomal Doxorubicin and Atezolizumab versus Pegylated Liposomal Doxorubicin/Bevacizumab and Atezolizumab versus Pegylated Liposomal Doxorubicin/Bevacizumab in Platinum Resistant Ovarian Cancer
    Trial ID: GY009
  • Title: ToRsemide comparison with furosemide FOR Management of Heart Failure
  • Title: A Phase IIR/III Trial of Standard of Care Therapy with or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
    Trial ID: NRG-BR002
  • Title: A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to axillary Radiation in Breast Patients (cT1-3N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
    Trial ID: A011202
  • Title: A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy with or without Enhanced Anti-Androgen Therapy with Apalutamide in Recurrent Prostate Cancer
    Trial ID: GU006
  • Title: A Prospective Observational Cohort Study to Develop a Predictive Model of Taxane-Induced Peripheral Neuropathy in Cancer Patients
    Trial ID: S1714
  • Title: Blood Sample Collection Evaluate Biomarkers in Subjects with Untreated Solid Tumors
    Trial ID: Exact Sciences-2018-01
  • Title: Managed Access Program (MAP) to provide alpelisb for patients with HR+ advanced or metastatic breast cancer resistant or refractory to available treatment options
    Trial ID: MAP
  • Title: A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers TRINOVA-3
    Trial ID: GOG 3001
  • Title: A Randomized Phase III Trial of the Value of Early Local Therapy for the intact Primary Tumor in Patients with Metastatic Breast Cancer
    Trial ID: E2108
  • Title: The Lymphedema and Gynecologic Cancer (LEG) Study; Incidence, Risk Factors, and Impact in Newly Diagnosed Patients
    Trial ID: LEG Study
  • Title: A Randomized, Phase 3 study of Ganetespib in Combination with Docetaxel Versus Docetaxel Alone in Patients with Advanced Non-Small Cell Lung Adenocarcinoma
    Trial ID: Galaxy 2
  • Title: A Prospective Longitudinal Study of CA 19-9 as an Aid in Monitoring Disease in Patients with Pancreatic Cancer
    Trial ID: FDI-68
  • Title: A Prospective Longitudinal Study of CA 15-3 as an Aid in Monitoring Recurrence or Progressive Disease in Patients with Breast Cancer
    Trial ID: FDI-69
  • Title: Clinical Evaluation of PRO-MComplete as an Aid in Determination of Rupture of Fetal Membranes
    Trial ID: PROM
  • Title: Multi-Center, Single Arm Prospective Clinical Evaluation of the Freedom Inguinal Hernia Repair System
    Trial ID: Freedom Mesh Study
  • Title: A Two Year Follo-Up, Post Implantation, Multi-Center, International Hernia Mesh Registry
    Trial ID: IHMR
  • Title: Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Srudy
    Trial ID: ARTEMIS
  • Title: Prospective Randomized Controlled Trial Comparing Resident Performance and Clinical Outcomes with Two Different Polypropylene Meshes for Laparoscopic Inguinal Hernias
    Trial ID: Dual Mesh
  • Title: A Randomized Controlled Trial to Reduce Adhesions Following a Primary Cesarean Section
    Trial ID: Seprafilm
  • Title: A Prospective, Multi-Center Study of Phasix Mesh for Venteral or Incisional Hernia Repair
    Trial ID: Davol-Bard
  • Title: ATLAS ( A prospective, multicenter Trial of a Long-term bio- Absorbable mesh with Sepra technology in challenging laparoscopic ventral or incisional hernia repair
    Trial ID: ATLAS-Phasix ST
  • Title: A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women with Recurrent Platinum-Resistant or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS) IND# 124225
    Trial ID: GY005
  • Title: A Randomized, Double-Blind, Phase III Study of Platinum+Pemetrexed Chemotherapy with or without Pembrolizumab (MK-3475) in First Line Metastatic Non-squamous Non-small Cell Lung Cancer Subjects (KEYNOTE-189)
    Trial ID: Merck KEYNOTE-189
  • Title: A Pragmatic Trial for Comprehensive Post-Acute Stroke Services (COMPASS)
    Trial ID: COMPASS
  • Title: A Randomized Phase III Trial of Memantine and Whole Brain Radiotherapy With or Without Hippocampal Avoidance in Patients with Brain Metastases
    Trial ID: NRG CC001
  • Title: Normal Range Values for Thromboelastography in Healthy Pregnant Volunteers
    Trial ID: TEG
  • Title: Preoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy For Borderline Resectable Adencarcinoma Of The Head Of The Pancreas
    Trial ID: Alliance A021501
  • Title: Reliability of Point of Care Pre-Hospital Ultrasound Interpretation in Patients Experiencing Traumatic Injuries
    Trial ID: Reliability of Point of Care Pre-Hospital Ultrasound Interpretation in Patients Experiencing Traumatic Injuries
  • Title: Getting to an Improved Understanding of Low Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD) a Registry of High Cardiovascular Risk Subjects in the United States
    Trial ID: Amgen (GOULD)
  • Title: Care Optimization Through Patient and Hospital Engagement for Heart Failure
    Trial ID: CONNECT-HF
  • Title: Tachy Prediction Download Study
    Trial ID: TPD
  • Title: Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair
    Trial ID: ATOMIC: Adjuvant Trial of Deficient Mismatch Repair in Colon Cancer
  • Title: Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry (SMART Registry)
    Trial ID: SMART
  • Title: Study to Determine the Safety of Utilizing Registered Diagnostic Cardiac Sonographers Assisting with Transesophageal Echocardiograms performed in the Cardiac Cath Lab and Electrophysiology Lab (SUSATEE
    Trial ID: SUSATEE
  • Title: AdaptResponse
    Trial ID: AdaptResponse